Clinical Trials Directory

Trials / Completed

CompletedNCT04757727

Gynecological Follow-up of Patients With Dystrophic Epidermolysis Bullosa (EBD)

Status
Completed
Phase
Study type
Observational
Enrollment
27 (actual)
Sponsor
Centre Hospitalier Universitaire de Nice · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers

Summary

Dystrophic epidermolysis bullosa is a rare genetic pathology resulting in fragility of the skin and mucous membranes, causing bubbles and wounds following trauma. Scarring is pathological with a tendency to retraction. The gynecological and in particular the vulvovaginal mucous membranes can be affected but no description of any series is available in the literature. Likewise, some of these patients have a sexual and obstetrical life, despite sometimes-severe damage, but again no specific data is available. The investitigator thus wish to carry out a non-interventional multicenter prospective descriptive study. Better knowledge of gynecological semiology in patients with EBD will allow better adaptation of gynecological follow-up, screening for STDs and gynecological cancers, as well as possible specific complications. This study would eventually allow the draw up of recommendations for our gynecologist / obstetrician colleagues.

Conditions

Interventions

TypeNameDescription
OTHERDecriptive study of EDBdata on EDB will be register

Timeline

Start date
2021-01-01
Primary completion
2021-09-30
Completion
2021-12-30
First posted
2021-02-17
Last updated
2025-04-03

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT04757727. Inclusion in this directory is not an endorsement.